Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours

Conditions:   Endometrial Cancer;   Gastric Cancer;   Metastatic Castration-resistant Prostate Cancer;   Ovarian Cancer;   Colorectal Cancer Interventions:   Drug: Datopotamab deruxtecan (Dato-DXd);   Drug: AZD5305;   Drug: Durvalumab;   Drug: Capecitabine;   Drug: 5-Fluorouracil;   Drug: Nivolumab;   Drug: Carboplatin;   Drug: Leucovorin LV;   Drug: Bevacizumab Sponsors:   AstraZeneca;   Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials